Targeting USP13 ‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer-Reference-Cited by-同舟云学术

Targeting USP13 ‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer

Published:2021-01-25 Issue:10 Volume:148 Page:2579-2593
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Giron Philippe¹²³,Eggermont Carolien¹²,Noeparast Amir¹,Vandenplas Hugo¹,Teugels Erik¹,Forsyth Ramses⁴,De Wever Olivier⁵,Aza‐Blanc Pedro⁶,Gutierrez Gustavo J.²,De Grève Jacques¹³^ORCID

Affiliation:

1. Laboratory of Medical and Molecular Oncology; Oncology Research Center, Faculty of Medicine and Pharmacy Vrije Universiteit Brussel Brussels Belgium

2. Laboratory of Pathophysiological Cell Signaling, Department of Biology, Faculty of Science and Bioengineering Sciences Vrije Universiteit Brussel Brussels Belgium

3. Center of Medical Genetics UZ Brussel Brussels Belgium

4. Laboratory of Anatomical and Experimental Pathology UZ Brussel Brussels Belgium

5. Laboratory of Experimental Cancer Research, Faculty of Medicine and Health Sciences Ghent University Ghent Belgium

6. Sanford‐Burnham‐Prebys Medical Discovery Institute La Jolla California USA

Funder

Belgian Federal Science Policy Office

Fonds Wetenschappelijk Onderzoek

Innoviris

Kom op tegen Kanker

Vrije Universiteit Brussel

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33404

Reference55 articles.

1. EGFR mutation incidence in non‐small‐cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII);Midha A;Am J Cancer Res,2015

2. Epidermal growth factor receptor mutations in lung cancer

3. The biology and management of non-small cell lung cancer

4. Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer

5. Afatinib in lung cancer harboring EGFR mutation in the LUX-Lung trials: six plus three is greater than seven?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies;Cancer Communications;2024-08-19

2. Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options;Molecular Cancer;2024-05-03

3. Roles of ubiquitin‑specific protease 13 in normal physiology and tumors (Review);Oncology Letters;2023-12-14

4. Oncogenic KRAS effector USP13 promotes metastasis in non-small cell lung cancer through deubiquitinating β-catenin;Cell Reports;2023-12

5. Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma;Cell Reports;2023-06